Emtora Biosciences
Rapamycin Holdings manufactures drugs to slow the aging process and treat age-related diseases.
Launch date
Employees
Market cap
-
Enterprise valuation
$10—15m (Dealroom.co estimates Jun 2015.)
San Antonio Texas (HQ)
| Date | Investors | Amount | Round |
|---|---|---|---|
N/A | Seed | ||
N/A | Convertible | ||
| N/A | $1.4m | Debt | |
| N/A | $2.5m | Series A | |
$3.0m | Grant | ||
* | $16.9m | Grant | |
| Total Funding | $22.4m | ||
Related Content
Recent News about Emtora Biosciences
EditTech stack
Tech stackLearn more about the technologies and tools that this company uses.